A Safety Study of TTP4000 in Subjects With Alzheimer's Disease

NCT01548430 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: TTP4000
DRUG: Placebo

Sponsor

vTv Therapeutics